In this presentation, the etiology and pathogenesis of hyponatremia (HN) will be discussed. HN is often asymptomatic or the symptoms are confused with other diseases. The symptoms and often severe consequences will be presented along with some general management recommendations. *Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Featured Speakers Location Online […]

In this presentation, the etiology and pathogenesis of hyponatremia (HN) will be discussed. HN is often asymptomatic or the symptoms are confused with other diseases. The symptoms and often severe consequences will be presented along with some general management recommendations. *Speakers are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Featured Speakers Location Online […]

A joint virtual live event for NephU & PsychU members in Oklahoma, New Mexico, Texas, and Arkansas. In this virtual live event, Sean George, PA-C, MHS and Laura Anguiano, PhD, discuss the high prevalence of major depressive disorder (MDD) among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Major depressive disorder affects […]

Most improvements in health care outcomes are attributed to clinical, operational, or financial process changes. However, patients can also play a considerable role in improving their care. Listen in as we explore patient empowerment and shared decision-making concepts, specific to patients suffering from kidney disease. By recognizing the potential benefit of empowered patients, it shifts the balance of care from the hospital and clinician to the community and patient – giving kidney patients a voice and control to improve outcomes!

Patient empowerment is an important concept in the care of patients with chronic kidney disease. This presentation discusses the foundational aspects of motivational interviewing, basic counseling techniques, and the importance of this collaborative counseling method in this population. By communicating and empowering patients, many outcomes have been shown to improve in chronic kidney disease.

With the advancement of technology throughout the 21st century, we have seen a growing role for the utilization of information technology applied to health and health care. Health information technology (HIT),including HIT used by patients, can play an important role in patient empowerment by creating new opportunities for patients and families to participate actively in their care management. In the Nephrology setting, HIT can help patients with chronic kidney disease be informed, engaged, committed, and collaborative in managing their health and care.

As part of our Patient Empowerment series, this presentation brings you concepts and resources to help improve health literacy among your patients, especially those with chronic kidney disease, as they manage the complexities of their care regimen. Health literacy is crucial for dialysis and transplant patients so they can be empowered to participate in shared decision-making. Effective communication strategies lead to better patient engagement, and engaged patients can better deal with the many challenges they face in living with kidney disease.

Patient empowerment is an important concept in the care of patients with chronic kidney disease (CKD). This presentation discusses the foundational aspects of motivational interviewing, basic counseling techniques, and the importance of this collaborative counseling method in this population. By communicating and empowering patients, many outcomes have been shown to improve in chronic kidney disease.

Join APKD experts, where you can hear the most current information on APKD pathophysiology, disease progression, and the physical and emotional burden of APKD.

In this virtual live event, Shirin Sundar, PhD and Becky Wong, PharmD, discuss the high prevalence of major depressive disorder (MDD) among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

In this virtual live event, Shirin Sundar, PhD and Becky Wong, PharmD, discuss the high prevalence of major depressive disorder (MDD) among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).

In this virtual live event, Alf Carroll, MS, PA-C, and Alyssa Peckham, PharmD, BCPP discuss the high prevalence of major depressive disorder (MDD) among patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD).